Literature DB >> 23358654

Therapeutic potential of EGCG on acute renal damage in a rat model of obstructive nephropathy.

Ping Zhou1, Jin Feng Yu, Cheng Guang Zhao, Feng Xuan Sui, Xu Teng, Yu Bin Wu.   

Abstract

As a major active component in green tea, (-)-epigallocatechin 3-O-gallate (EGCG) has many anti-oxidative activities. This study investigated whether intraperitoneal administration of EGCG was capable of suppressing oxidative stress in rats with unilateral ureteral obstruction (UUO) and probed the potential mechanisms involved. In total, 150 adult male rats were randomly divided into 5 groups (n=30 each): the control group (group N); the unilateral ureteral obstruction (UUO) group (group C), where the unilateral ureter was ligated resulting in an obstructive nephropathy model; and the EGCG group (group T), following unilateral ureteral ligation, rats were intraperitoneally injected with EGCG at a dosage of 2.5 (T1), 5 (T2) and 10 mg/kg/day (T3). Each group of rats was sacrificed 72 h after surgery. We evaluated the effects of EGCG on the reactive oxygen species (ROS), reduced glutathione (GSH), oxidized glutathione (GSSG) and glutathione in the renal tissue of rats. Immunohistochemistry and western blot analysis were applied to detect nuclear factor erythoid-derived 2-related factor 2 (Nrf2) and γ-glutamylcysteine synthetase (γ-GCS) protein expression. Real-time PCR was performed to detect the mRNA levels of Nrf2 and γ-GCS. Changes in renal ultrastructure were also observed using electron microscopy. There was no significant difference in GSH, and compared with group N, ROS, GSSG and total GSH levels were much higher in the T groups (p<0.01), while much lower than those of group C (p<0.01). Protein levels of Nrf2 and γ-GCS and the mRNA levels of Nrf2 and γ-GCS notably increased in EGCG-treated rats (all p<0.05). Furthermore, electron microscopy showed that renal ultrastructure was improved in the treatment groups. Our findings suggest that, resulting from suppression of oxidative stress influenced by free radicals, EGCG exerts a protective effect on rats with obstructive nephropathy, and this anti-oxidative effect may be partly induced by activating the Nrf2 signaling pathway.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23358654     DOI: 10.3892/mmr.2013.1296

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  19 in total

Review 1.  The Green Tea Polyphenol(-)-epigallocatechin-3-gallate and its beneficial roles in chronic kidney disease.

Authors:  Hui Bao; Ai Peng
Journal:  J Transl Int Med       Date:  2016-09-23

2.  The effect of epigallocatechin-3-gallate on the renal dysfunction in the obstructed kidney in the rat.

Authors:  Fayez T Hammad; Loay Lubbad
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2017-09-01

3.  Epigallocatechin gallate suppresses hepatic cholesterol synthesis by targeting SREBP-2 through SIRT1/FOXO1 signaling pathway.

Authors:  Yongnan Li; Shuodong Wu
Journal:  Mol Cell Biochem       Date:  2018-02-14       Impact factor: 3.396

4.  Protective Effects of Epigallocatechin-3-Gallate from Green Tea in Various Kidney Diseases.

Authors:  Rattiyaporn Kanlaya; Visith Thongboonkerd
Journal:  Adv Nutr       Date:  2019-01-01       Impact factor: 8.701

5.  Epigallocatechin-3-gallate attenuates unilateral ureteral obstruction-induced renal interstitial fibrosis in mice.

Authors:  Yanqiu Wang; Bowen Wang; Feng Du; Xuesong Su; Guangping Sun; Guangyu Zhou; Xiaohui Bian; Na Liu
Journal:  J Histochem Cytochem       Date:  2014-12-30       Impact factor: 2.479

Review 6.  Mediators and mechanisms of heat shock protein 70 based cytoprotection in obstructive nephropathy.

Authors:  Luciana Mazzei; Neil G Docherty; Walter Manucha
Journal:  Cell Stress Chaperones       Date:  2015-07-31       Impact factor: 3.667

7.  Association of prohibitin-1 and 2 with oxidative stress in rats with renal interstitial fibrosis.

Authors:  Tian-Biao Zhou; Yuan-Han Qin; Feng-Ying Lei; Wei-Fang Huang; Gregor P C Drummen
Journal:  Mol Biol Rep       Date:  2014-03-05       Impact factor: 2.316

8.  Mitochondrial modulation by Epigallocatechin 3-Gallate ameliorates cisplatin induced renal injury through decreasing oxidative/nitrative stress, inflammation and NF-kB in mice.

Authors:  Hao Pan; Jun Chen; Kezhen Shen; Xueping Wang; Ping Wang; Guanghou Fu; Hongzhou Meng; Yimin Wang; Baiye Jin
Journal:  PLoS One       Date:  2015-04-15       Impact factor: 3.240

9.  Targeting HO-1 by Epigallocatechin-3-Gallate Reduces Contrast-Induced Renal Injury via Anti-Oxidative Stress and Anti-Inflammation Pathways.

Authors:  Zhao Gao; Yu Han; Yunhui Hu; Xiaoyan Wu; Yongbin Wang; Xiaoqun Zhang; Jinjuan Fu; Xue Zou; Jun Zhang; Xiongwen Chen; Pedro A Jose; Xi Lu; Chunyu Zeng
Journal:  PLoS One       Date:  2016-02-11       Impact factor: 3.240

Review 10.  Mitochondria: a new therapeutic target in chronic kidney disease.

Authors:  Simona Granata; Alessandra Dalla Gassa; Paola Tomei; Antonio Lupo; Gianluigi Zaza
Journal:  Nutr Metab (Lond)       Date:  2015-11-25       Impact factor: 4.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.